consultant, pediatric hematology oncology
head of hematology unit, alaziziyah children hospital
supervisor of blood disease centers in jeddah directorate health affair
Pediatric hematology oncology consultant
President congress
Consultant Pediatrics Hematology / Oncology
King Salman Medical City.
Professor of Hematology
University of Hertfordshire.
MD, President, MENA Hematology League
Team Leader
profession as a haematologist and blood transfusion specialist
Egyptian Society of Hemophilia
MD, President, HEMNET
The MENA Hematology Congress is an annual event that focuses on the latest advances and breakthroughs in the field of hematology. The congress brings together hematologists, researchers, clinicians, and other healthcare professionals from the Middle East and North Africa region to share their expertise, knowledge, and experience. The congress usually covers a wide range of topics related to hematology, including blood disorders, hematologic malignancies, stem cell transplantation, and other related fields. It provides a platform for researchers and clinicians to present their latest research findings, clinical studies, and case reports. In addition to the scientific sessions, the MENA Hematology Congress also includes keynote speeches, workshops, and panel discussions on various topics related to hematology. The congress provides a unique opportunity for attendees to network with their peers, exchange ideas, and collaborate on future research projects. Overall, the MENA Hematology Congress is a must-attend event for anyone interested in the latest developments in hematology and related fields. It provides a platform for sharing knowledge and expertise, promoting collaboration, and advancing the field of hematology in the Middle East and North Africa region.
The MENA Hematology Congress is an annual event that focuses on the latest advances and breakthroughs in the field of hematology. The congress brings together hematologists, researchers, clinicians, and other healthcare professionals from the Middle East and North Africa region to share their expertise, knowledge, and experience. The congress usually covers a wide range of topics related to hematology, including blood disorders, hematologic malignancies, stem cell transplantation, and other related fields. It provides a platform for researchers and clinicians to present their latest research findings, clinical studies, and case reports. In addition to the scientific sessions, the MENA Hematology Congress also includes keynote speeches, workshops, and panel discussions on various topics related to hematology. The congress provides a unique opportunity for attendees to network with their peers, exchange ideas, and collaborate on future research projects. Overall, the MENA Hematology Congress is a must-attend event for anyone interested in the latest developments in hematology and related fields. It provides a platform for sharing knowledge and expertise, promoting collaboration, and advancing the field of hematology in the Middle East and North Africa region.
consultant, pediatric hematology oncology
head of hematology unit, alaziziyah children hospital
supervisor of blood disease centers in jeddah directorate health affair
Pediatric hematology oncology consultant
Al aziziyah children hospital
The MENA Hematology Congress is an annual event that focuses on
the latest advances and breakthroughs in the field of hematology. The congress brings together hematologists, researchers, clinicians, and other healthcare professionals from the Middle East and North Africa region to share their expertise, knowledge, and experience. The congress usually covers a wide range of topics related to hematology, including blood disorders, hematologic malignancies, stem cell transplantation, and other related fields. It provides a platform for researchers and clinicians to present their latest research findings, clinical studies, and case reports. In addition to the scientific sessions, the MENA Hematology Congress also includes keynote speeches, workshops, and panel discussions on various topics related to hematology. The congress provides a unique opportunity for attendees to network with their peers, exchange ideas, and collaborate on future research projects. Overall, the MENA Hematology Congress is a must-attend event for anyone interested in the latest developments in hematology and related fields. It provides a platform for sharing knowledge and expertise, promoting collaboration, and advancing the field of hematology in the Middle East and North Africa region.
consultant, pediatric hematology oncology
head of hematology unit, alaziziyah children hospital
supervisor of blood disease centers in jeddah directorate health affair
Pediatric hematology oncology consultant
Al aziziyah children hospital
The aim of the congress is to provide attendees with the latest updates in hematology research, diagnosis, and treatment, and to enhance their knowledge and skills in the field. The congress also aims to raise awareness about the latest developments in the field of hematology and to foster collaboration and partnerships among healthcare professionals in the region
The target audience for the MENA Hematology Congress includes
| 07:00 – 08:00 | Registration / Exhibition Tour | |
|---|---|---|
| 08:00 – 09:00 | PFIZER SYMPOSIUM SCD Unmet Medical Needs Chairman: Hussain Alsaeed Speaker: Sarah Sewaralthahab ( KSA) |  |
| Hemoglobinopathies (1) Mena-HL / Madinah Hbd Society Joint Session Chairperson: Muhammad Faisal khanani (UAE) Mohammad Zolali (KSA) | ||
| 09:00 – 09:20 | Thalassemia Endocrinopathy | Melanie Kirby (Canada) |
| 09:20 – 09:40 | Novel Therapies in Thalassemia | Melanie Kirby (Canada) |
| 09:40 – 10:00 | Hepathopathy in Sickle Cell Anemia | Anas Hakim (KSA) |
| 10:00 – 10:20 | Novel Therapies in Sickle Cell Anemia | Ahmad Tarawah (KSA) |
| 10:20– 10:30 | Discussion | |
| Launch of Exhibition | ||
| Break/Exhibition tour | ||
| Keynote Lecture Mena-HL / TIF Joint Session | ||
| 10:45 – 11:15 | Gene Therapy in Hemoglobinopathies | Andreas Kulozik (Germany) |
| Hemoglobinopathies (2) Mena-HL / TIF Joint Session Moderators: Ahmad Tarawah (KSA) Abdullah Aljefri (KSA) | ||
| 11:15 – 11:35 | Stem Cells Transplant In Hemoglobinopathies | Mohsen Alzahrani (KSA) |
| 11:35– 11:55 | Psychological Support For Patients And Families | Ahmad Hafiz (KSA) |
| 11:55 – 12:00 | Discussion | |
| Lunch – Prayer Break – Exhibition tour | ||
| 12:45 -13:30 | PFIZER SYMPOSIA Advanced Approaches in SCD Management Chairman: Sultan Al Mutari Speaker: Caterina Minniti ( USA) | |
| 13:30 – 14:15 | ASTRAZENECA SYMPOSIUM Think IVH: The Role of C5i in PNH Management Chairperson: Eman Hazmi Speaker: Sultan Al Motairi |  |
| KEYNOTE LECTURE | ||
| 14:15 – 14:45 | Management Strategies for acute Pediatrics Thrombosis | Abdulqader Al-hebshi (Canada) |
| THROMBOSIS / TTP Moderators: Hadil Saleh (Kuwait) Arwa Yamani (KSA) | ||
| 14:45 – 15:00 | TTP Pathophysiology / Management | Sultan Almutairi(KSA) |
| 15:00 – 15:15 | Hemophagocytic Lymphohistiocytosis | Sami Althubaiti (KSA) |
| 15:15 – 15:30 | Updated Guidelines, Adult Thrombosis | Ashraf Warsi (KSA) |
| Break / Exhibition tour | ||
| Neonatal Hematology Moderators: Mohammad Darwish (KSA) Waheed Turkostani (KSA) | ||
| 15:45 – 16:00 | Neonatal Transfusion | Nour AlMozain (KSA) |
| 16:00 – 16:15 | Neonatal Thrombocytopenia | Arwa Alyamani (KSA) |
| 16:15 – 16:30 | Neonatal Thrombosis | Azzah Alzahrani (KSA) |
| 16:30 – 16:45 | Protein C Deficiency | Arwa Alyamani (KSA) |
| 16:45 – 16:55 | Discussion | |
| Thursday 26 October 2023 Track II | ||
|---|---|---|
| PHYSIOTHERAPY SESSION (1) Facilitators: Cesar Haddad (Lebanon) Khalid Alhadidi (KSA) | ||
| 13:00 – 13:30 | Hemophilia and other bleeding disorders | Ahmad Tarawah (KSA) |
| 13:30 – 14:00 | Hemarthrosis, Synovitis, Hematomas | Mohammed Alshamli (Oman) |
| 14:00 – 14:30 | Physiotherapy Assessment tools in bleeding disorders | Khalid Alhadidi (KSA) |
| 14:30 – 15:00 | Physiotherapy therapeutic options | Cesar Haddad (Lebanon) |
| 15:00 – 15:15 | Discussion | |
| Break / Exhibition tour | ||
| PHYSIOTHERAPY SESSION (2) Facilitators: Mohammad Shamli (Oman) Khalid Alhadidi (KSA Cesar Haddad (Lebanon) Mohammed Abu Hagar (Egypt) Rashed AlGamdi (KSA) | ||
| 15:45 – 17:15 | Wet workshop |
| Friday 27 October 2023 Track II | ||
|---|---|---|
| 7:00 – 8:00 | Registration / Exhibition tour | |
| Best Abstracts Moderators: Azza Abduljawad (Egypt) Salem Bahashwan (KSA) | ||
| 08:00 – 08:10 | Allogeneic Hematopoietic Stem Cell Transplantation In Aplastic Anemia: Experience Of The Pediatric Hematology And Oncology Department In Rabat (Morocco) | M Lakhrissi (Morocco) |
| 08:10 – 08:20 | Subclinical Atherosclerosis In Childhood Acute Lymphoblastic Leukemia Survivors: A Tertiary Center Experience | Laila Sherief (Egypt) |
| 08:20 – 08:30 | Long Term Outcome Of Allogeneic Stem Cell Transplantation For Patients With Fanconi Anemia | Khayati Malak (Tunisia) |
| 08:30 – 08:40 | BCL2 Overexpression In Diffuse Large B-Cell Lymphoma | Hajar Masrour (Morocco) |
| 08:40 – 08:50 | Coexistence Of JAK2V617F And CALR Mutation In Tunisian Cohort With Philadelphia-Negative Chronic Myeloproliferative Neoplasms | Hejer Elmahmoudi (Tunisia) |
| 08:50 – 09:00 | The Perception Of Pediatric Sickle Cell Anemia Patients’ Caregivers Toward Bone Marrow Transplantation At NGHA Jeddah, Saudi Arabia | Manar Betar (KSA) |
| 09:00 – 09:10 | Refractory Diffuse Large B-Cell Lymphoma | Hajar Masrour (Morocco) |
| 09:10 – 09:20 | Effect Of Low Dose Of Hydroxyurea In SCD Children With Arab-Indian Phenotype- Local Experience | Zahra Hussein (KSA) |
| 09:20 – 09:30 | The Effect Of Different Types Of Anemia On Hba1c Levels In Non-Diabetics | Basil Alzahrani (KSA) |
| 09:30 – 09:40 | Case Series With Haemoglobin Hope In Egyptian Family | Amal Moustafa (Egypt) |
| 09:40 – 09:50 | The Multidimensional Impact Of Sickle Cell Disease In Children On Parents And Family Functioning: A Cross Sectional Study | Raed Alfayez (KSA) |
| 09:50 – 10:00 | Assessing Bone Mineral Density in Sickle Cell Disease Patients & Correlation to Frequency of Admission – Prospective – Uni Center Study | Rehab AL-Ansari (KSA) |
| 4th Gulf Thrombosis and Hemostasis Conference (GGTH) HEMATOLOGY THE POWER OF PHARMACISTS | ||
Moderators: Saad Alhashmi (Ksa) Ibrahim Alharbi (Ksa) | ||
| 10:15 – 10:45 | Overview of bleeding disorders | Saud Balilah (KSA) |
| 10:45 – 11:15 | Harnessing The Expertise Of Specialized Pharmacist In Hemophilia Management, Navigating The New Era | Marwa Elhadidy (KSA) |
| 11:15 – 11:45 | Chemotherapy Stewardship: A Comprehensive Program to Improve Effectiveness and Efficiency of Cancer Care | Anas Hamad (Qatar) |
| 11:45 – 12:15 | Approaches In Treatment Of Beta-Thalassemia: Optimistic Review And New Opportunities | Aeshah AlAzmi (KSA) |
| 12:15 – 12:20 | Discussion | |
| Lunch / Prayer Break / Exhibition tour | ||
| 4th Gulf Thrombosis and Hemostasis Conference (GGTH) HEMOPHILIA AND BLEEDING DISORDERS THE POWER OF DENTISTS | ||
| 13:00 – 13:10 | Opening Remarks Ahmad Tarawah (KSA) Amal AlKhotani (KSA) Ohoud Kashari (KSA) | |
| SESSION I | Chairperson: Zikra Alkhayal (KSA) Amal AlKhotani (KSA) | |
| 13:10 – 13:35 | Overview of bleeding disorders | Saud Balelah (KSA) |
| 13:35 – 14:00 | Across Saudi Arabia’s sand, each blood drop out of our children is precious (epidemiology) | Linda Mirza (KSA) |
| 14:00 – 14:25 | The multidisciplinary approach for children with bleeding disorders | Amal AlKhotani(KSA) |
| 14:25 – 14:50 | Dental imaging of patients with bleeding disorders | Fatima Jadu (KSA) |
| 14:50 – 15:15 | GCC dental guidelines for bleeding disorders | Zikra Alkhayal (KSA) |
| 15:15 – 15:20 | Discussion | |
| Break / Exhibition tour | ||
| SESSION II | Moderators: Abeer Al-Namankany(KSA) Hana Alkaroby (KSA) | |
| 15:45 – 16:10 | Hematologist consultation guide for risk and dental care dilemma | Raniah Baakdah (KSA) |
| 16:10 – 16:35 | Management of hemophilic children experiencing full mouth rehabilitation under general anesthesia | Abeer Al-Namankany (KSA) |
| 16:35 – 16:55 | Experience from Egypt: national dental guidelines | Hitham Shaaban (Egypt) |
| 16:55 – 17:15 | Abstract: Oral health status and the impact of Oral health promotion in Children& Adolescents with Bleeding Disorders | Nayera Abdelhafez (Egypt) |
| 17:15 – 17:30 | Discussion |
| Saturday 28 October 2023 Track II | ||
|---|---|---|
| 07:00 – 08:00 | Registration / Exhibition tour | |
| 08:00 – 08:45 | BMS SYMPOSIUM Beta Thalassemia Evolving Treatment Options Beyond Transfusion Chairperson: Dr. Hussain Alsaid Speaker: Prof. Aamer Aleem |  |
| Hemoglobinopathies (3) Moderators: Amal El Beshlawy (Egypt) Fahad Almohareb (Ksa) | ||
| 08:45 – 09:00 | RBCs Exchange | Iman Alhazmi (KSA) |
| 09:00 – 09:15 | Pediatrics RBCs Exchange: Madinah’s experience | Mohamed Nashat (KSA) |
| 09:15 – 09:30 | Sickle Cell Disease: Egypt experience | Amal El Beshlawy (Egypt) |
| 09:30 – 09:40 | Discussion | |
| Leukemia (I) Moderators: Mohamed Meabed (Egypt) Ibrahim Abusaadah (Ksa) | ||
| 09:40 – 10:00 | Update Approach To Relapsed ALL In Children | Mohammed Essa (KSA) |
| 10:00 – 10:20 | Ph Positive ALL | suleimman alsweedan (Jordan) |
| 10:20 – 10:30 | Discussion | |
| Break / Exhibition tour | ||
| LEUKEMIA (II) Moderators: Ahmad AlSoliman (KSA) Basim AlBeirouti (KSA) | ||
| 10:50 – 11:10 | FLT3 AML | Zeyad AlShaibani (KSA) |
| 11:10 – 11:30 | Umbilical Cord Blood Stem Cell Transplant | Mayada Abu Shanap (Jordan) |
| 11:30– 11:50 | Update On CAR T Cell Therapy | Ali Alahmari (KSA) |
| 11:50 – 12:00 | Discussion | |
| Lunch / Prayer Break / Exhibition tour | ||
| MYELODYSPLASTIC SYNDROMES Moderators: suleimman alsweedan (Jordan) Hafez Malhan (KSA) | ||
| 13:00 – 13:20 | Myelodysplastic Syndromes | Walaa Rajkhan (KSA) |
| 13:20– 13:40 | CML treatment updates | Ahmad Alsaeed (KSA) |
| 13:40 – 14:00 | The journey from clonal hematopoiesis to MDS | Hanan Hamed (Egypt) |
| Discussion | ||
| MULTIPLE MYELOMA / LYMPHOMA Moderators: Tarek Owidah (KSA) Mohammed Zolaly (KSA) | ||
| 14:10 – 14:30 | Multiple Myelomas Novel Therapies | Majed Alahmady (KSA) |
| 14:30 – 14:50 | Update In Hodgkin Lymphoma | Angela Punnett (Canada) |
| 14:50 – 15:10 | Precision Medicine In Pediatric Oncology | Souad AlJauni (KSA) |
| 15:10 – 15:20 | Discussion | |
| BREAK / Exhibition tour | ||
| COUNTRIES / SOCIETIES REPORT Moderators: Murtada Hassan (Iraq) Ahmad Tarawah (KSA) | ||
| 15:45 – 16:00 | MENA Hematology League | Ahmad Tarawah (KSA) |
| 16:00 – 16:15 | Saudi Society of Blood Disorders | Tarek Owidah (KSA) |
| 16:15 – 16:30 | Thalassemia / SCA Friends Association | Badryah AlGamdi (KSA) |
| 16:30 – 16:45 | Madinah Hereditary Blood Disorders Society | Saud Balilah (KSA) |
| 16:45 – 17:00 | Saudi Hemophilia Society | Mohammad AlShahrani (KSA) |
Membership Requirement: Please note that in order to register for the conference, you must be a member of the MENA Hematology Society .
If you’re not already a member, you can join us today.
Please note, if membership registration is not completed within 24 hours, conference registration will be cancelled
Once your membership is confirmed, you’ll be able to register for the conference using the following fee structure:
Ⓒ 2023 All Rights Reserved – Mena Hematology LEAGUE
Developed By | 
Contact Us